As a DNA repair protein, Flap endonuclease 1 (FEN1) plays crucial parts in preventing carcinogenesis. Two functional germ line variants (-69G > A and 4150G > T) in the FEN1 gene have been associated with DNA damage levels in coke oven workers and lung cancer risk in general populations. However, the role of these genetic variants on gastrointestinal cancer susceptibility is unknown. Therefore, we evaluated the association between these polymorphisms and gastrointestinal cancer risk in two independent casecontrol cohorts consisted of a total of 1850 gastrointestinal cancer (hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer) patients and 2222 healthy controls. The impact of these variations on FEN1 expression was also examined using liver, esophagus, stomach and colon normal tissues. It was found that the FEN1 -69GG genotypes were significantly correlated to increased risk for developing gastrointestinal cancer compared with the -69AA genotype in both cohorts [Jinan cohort: odds ratios (OR) 5 2.14, 95% confidence interval (CI) 5 1.47-2.80, P 5 1.0 3 10 26 ; Huaian cohort: OR 5 1.93, 95% CI 5 1.37-2.50, P 5 0.5 3 10 26 ]. Similar results were observed for 4150G > T polymorphism. In the combined meta-analyses, OR for -69GG or 4150GG genotype was 2.02 (95% CI 5 1.59-2.45) or 1.86 (95% CI 5 1.45-2.28) compared with -69AA or 4150TT genotype. In vivo FEN1 messenger RNA expression analyses showed that the -69G or 4150G allele carriers had $2-fold decreased FEN1 expression in gastrointestinal tissues compared with -69A or 4150T carriers, indicating that lower FEN1 expression may lead to higher risk for malignant transformation of gastrointestinal cells. Our results highlight FEN1 as an important gene in human gastrointestinal oncogenesis and genetic polymorphisms in FEN1 confer susceptibility to gastrointestinal cancers.
Introduction
As a structure-specific nuclease, Flap endonuclease 1 (FEN1) is involved in efficient 5#-flap removal during long-patch base excision repair and the maturation of Okazaki fragments in DNA replication (1) (2) (3) . Additionally, FEN1 also acts as a 5# exonuclease (4) and a gap-dependent endonuclease (5, 6) , which can be stimulated to promote apoptotic DNA fragmentation after apoptotic stimuli. Due to its pivotal role in DNA repair and other multiple DNA metabolic pathways, FEN1 can serve as a key enzyme in maintaining genomic stability and protecting against carcinogenesis (1) (2) (3) (4) (5) (6) . It was reported that the functional impairment of yeast RAD27 (the homolog of mammalian FEN1) leads to a remarkable increase in the rate of spontaneous mutations (6) (7) (8) . Haploinsufficient FEN1 can result in genome instability and carcinogenesis in mice (9) . It has also been shown that FEN1 mutations resulting in reduced nuclease activity occur in human cancer cells and 70% of mice knocked-in the mutated FEN1 developed tumors in multiple organs (10) . Therefore, abnormal expression of FEN1 resulting from naturally occurring genetic variants may contribute to cancer susceptibility.
Previously, two single-nucleotide polymorphisms (SNPs), -69G . A (rs174538, in the gene promoter region) and 4150G . T (rs4246215, in gene 3#-untranslated region), were identified after thoroughly re-sequencing the FEN1 locus in 30 Chinese Han healthy volunteers (11) . Electrophoretic mobility-shift assays and luciferase assays showed that -69G . A SNP causes increased promoter activity, which is most likely to be due to a higher binding affinity of the G allele with some unknown transcriptional inhibitors. In addition, the 4150G . T SNP is also associated with differential levels of FEN1 RNA expression. Real-time analysis of FEN1 RNA in lung tissues also suggested that both -69G . A and 4150G . T SNPs could influence gene expression in vivo. These SNPs were reproducibly associated with lung cancer risk in two independent cohorts (Beijing cohort: 1013 lung cancer patients and 1131 controls; Wuhan cohort: 827 lung cancer patients and 827 controls).
However, their roles on gastrointestinal cancer susceptibility and impact on FEN1 expression in gastrointestinal tissues are still unknown. Therefore, we specifically examined whether these two polymorphisms are involved in development of four gastrointestinal cancers, including hepatocellular carcinoma (HCC), esophageal cancer (EC), gastric cancer (GC) and colorectal cancer (CRC), in two independent case-control cohorts from Jinan city (Shandong Province) and Huaian city (Jiangsu Province). To validate the biological function of these two SNPs in vivo, we also examined the association between FEN1 genotypes and FEN1 messenger RNA (mRNA) expression levels in liver, esophagus, stomach and colorectal tissues.
Materials and methods

Study cohorts
This study consisted of two case-control cohorts (i) Jinan cohort: 1022 patients with gastrointestinal cancers (410 HCC cases, 266 EC cases, 220 GC cases and 126 CRC cases) from Shandong Cancer Hospital, Shandong Academy of Medical Sciences (Jinan, Shandong Province, China) and sex-and age-matched (±5 years) 1221 controls. Patients were recruited between June 2009 and May 2011 at Shandong Cancer Hospital. All patients had not been treated by any medical treatments. The diagnosis of EC, GC and CRC patients were histologically confirmed. For HCC, diagnosis of patients was confirmed by a pathological examination combined with positive imaging (magnetic resonance imaging and/or computerized tomography). Control subjects were randomly selected from a pool of 4200 individuals from a community cancer-screening program for early detection of cancer conducted in Jinan city during the same time period as the patients were collected. Polymorphism genotyping FEN1 -69G . A and 4150G . T genotypes were examined using polymerase chain reaction (PCR)-based restriction fragment length polymorphism as previously reported (11) . In PCR-restriction fragment length polymorphism genotyping, the primers used for amplifying DNA segments containing the either FEN1 -69G . A or 4150G . T sites were 5#-ggaggttccaggagcgtcta-3#/5#-ttctccaccgcttgtccc-3# or 5#-tatgtcaggctcaaaccac-3#/5#-cagccagtaatcagtcacaa-3#, respectively. Restriction enzyme SalI (New England Biolabs) or Alw26I (Fermentas) was used to distinguish the-69G . A or 4150G . T genotypes, respectively. A 15% random sample was reciprocally tested by direct sequencing, and the reproducibility was 99.8%.
Real-time analysis of FEN1 mRNA SYBR-Green real-time quantity PCR method was used to examine FEN1 mRNA levels in normal tissues as described previously (11) . In brief, total RNA was isolated and converted to complementary DNA using an oligo(dT) 15 primer and Superscript II (Invitrogen). Relative gene expression quantitation for FEN1 and b-actin as an internal reference gene was carried out using the ABI 7500 real-time PCR system in triplicates. The primers used for FEN1
were 5#-ctgtggacctcatccagaagca-3# and 5#-ccagcacctcaggttccaaga-3# and for b-actin were 5#-ggcggcaccaccatgtaccct-3# and 5#-aggggccggactcgtcatact-3#.
Statistics
The associations between FEN1 genotypes and risk of gastrointestinal cancers were estimated by odds ratios (ORs) and their 95% confidence intervals (CIs) computed by logistic regression models. Student's t-test was used to assess differences in FEN1 transcript abundance with different genotypes. All ORs were adjusted for age, sex, smoking, drinking or hepatitis B virus infection status, where it was appropriate. In the meta-analyses, association between FEN1 polymorphisms and gastrointestinal cancer risk was re-calculated using crude ORs together with their corresponding 95% CIs. If the P value of the heterogeneity test was !0.05, a fixed effect model (the Mantel-Haenszel method) was performed to calculate the combined OR (12) , which assumed the same homogeneity of effect size across all studies. If the P value of the heterogeneity test was ,0.05, it showed that the between-study heterogeneity was statistically significant. A random effects mode (the DerSimonian and Laird method) was used to calculate the combined OR (13) . A P value of ,0.05 was used as the criterion of statistical significance, and all statistical tests were two-sided. All analyses were performed using SAS 9.0 (SAS Institute) and Stata 11.0 (StataCorp LP).
Results
The subject characteristics are shown in Table I . All observed genotype frequencies in both controls and patients conform to HardyWeinberg equilibrium. The allelic frequencies for the -69A and 4150T were 0.364 and 0.360 among 1221 (1220 for 4150T) healthy controls in Jinan cohort and 0.458 and 0.457 among 1001 control Table I . Distribution of selected characteristics among gastrointestinal cancer patients and controls Figure 1B) . In Jinan cohort, individuals with FEN1 -69GA genotype were only significantly associated with increased risk of HCC (OR 5 1.78, 95% CI 5 1.15- Figure 1A ). In the combined meta-analyses, we found that the -69GG genotype had a 2.14-or 1.93-fold increased risk for gastrointestinal cancer compared with the -69AA genotype in Jinan cohort or Huaian cohort (95% CI 5 1.47-2.80, P 5 1.0 Â 10 À6 or 95% CI 5 1.37-2.50, P 5 3.5 Â 10 À6 ). Interestingly, although the heterozygous -69GA genotype was not significantly associated with GC and CRC risks in both cohorts, pooled analyses also suggest that -69GA genotype had a OR of 1.62 (95% CI 5 1.13-2.10, P 5 0.009) or 1.61 (95% CI 5 1.17-2.05, P 5 3.4 Â 10 À4 ) in Jinan or Huaian cohort compared with AA genotype. Overall, results from 1850 gastrointestinal cancer cases and 2222 healthy controls showed that FEN1 -69GG and GA genotypes were associated with increased gastrointestinal cancer risk compared with AA genotype (OR 5 2.02, 95% CI 5 1.59-2.45 or OR 5 1.61, 95% CI 5 1.29-1.94) ( Figure 1A) . Similar results were observed for 4150G . T polymorphism. The 4150GG and GT genotypes had a 1.86-and 1.54-fold increased risk compared with the 4150TT genotype (95% CI 5 1.45-2.28 and 95% CI 5 1.22-1.87) ( Figure 1B ). Although stratification analyses by age, sex or smoking status were also conducted, nothing interesting was observed (data not shown).
Haplotype analyses showed that A À69 G 4150 , G À69 G 4150 and G À 69 T 4150 haplotypes were associated with increased risk of developing gastrointestinal cancer in Jinan cohort, with the adjusted ORs being 1.38 (95% CI 5 1.28-1.64; P 5 2.7 Â 10 À6 ), 2.35 (95% CI 1.44-3.91; P 5 4.9 Â 10 À4 ) and 4.06 (95% CI 5 2.78-5.88; P 5 1.5 Â 10 À14 ) compared with the A À69 T 4150 haplotype (Table IV) . However, in Huaian cohort, only the G À69 T 4150 haplotype was associated with significantly increased risk of developing gastrointestinal cancer (OR 5 1.29, 95% CI 5 1.12-1.39) compared with the A À69 T 4150 haplotype (Table IV) .
Since there is an allele-specific effect of -69G . A and 4150G . T SNPs on FEN1 expression in lung tissues, we examined if similar phenomena could be observed in gastrointestinal tissues. As shown in Figure 2 , we found that subjects with the -69AA genotype had significantly higher FEN1 RNA levels (mean ± SE) than those with the -69GG and GA genotypes in liver, esophagus, stomach and colorectal normal tissues [liver: 0.217 ± 0.038 (n 5 5) versus 0.099 ± 0.013 (n 5 15), P , 0.001; esophagus: 0.242 ± 0.015 (n 5 4) versus 0.108 ± 0.042 (n 5 11), P 5 0.005; stomach: 0.268 ± 0.060 (n 5 3) Similar results were observed when the FEN1 RNA levels were compared as a function of 4150G . T genotypes (data not shown).
Discussion
As an important tumor suppressor, depressed FEN1 expression may lead to malignant transformation of normal gastrointestinal cells (14) . Interestingly, FEN1 -69G and 4150G alleles, which are correlated to significantly decreased FEN1 mRNA expression in normal gastrointestinal tissues, are associated with increased gastrointestinal cancer risks compared with -69A and 4150T alleles in two independent casecontrol cohorts. These results are consistent to our previous findings in lung cancer (11) , indicating that these SNPs may be common cancer risk factors.
There is an obvious difference in the allelic and genotype frequencies of both -69G . A and 4150G . T SNPs in two Chinese populations included in the current study. After comparing genotype frequencies of normal healthy controls with our previous observation in Beijing and Wuhan populations, we believe that Jinan population is more similar to Beijing population, but Huaian population is similar to Wuhan population. These results also support our opinion that FEN1 SNPs may be relatively novel, probably resulting from certain different evolutional pressures in different geographical areas. In spite of the difference between populations, these SNPs are consistently associated with risk of gastrointestinal cancers in two cohorts.
FEN1 -69G . A and 4150G . T SNPs were positively correlated to risk of HCC, EC and GC but not risk of CRC in the current study. However, FEN1 mRNA expression results showed that these two genetic variants could also influence FEN1 expression in vivo, suggesting these two SNPs are also functional in colorectal cells. Negative results of the case-control studies may be due to the relative small sample size (126 patients in Jinan cohort and 110 in Huaian cohort). Therefore, these results on CRC warrant to be validated in other cohort in the future.
In summary, FEN1 -69G . A and 4150G . T SNPs are common genetic risk factors for gastrointestinal cancers in Chinese populations. Given this fact, further efforts are warranted to explore whether FEN1 genetic polymorphisms could be potentially useful for diagnosis of gastrointestinal cancers. FEN1 polymorphisms in gastrointestinal cancer
